Very Long-Term Prognostic Value of Ventricular Late Potentials in Patients With St-Elevation Myocardial Infarction

Alexander Shturman 1,3 Shira Vardi 1,3 Amitai Bickel 2,3 Orly Yakir 1,3 Shaul Atar 1,3
1Cardiology, Medical Center of the Galilee, Nahariya, HaZafon
2Surgery A, Medical Center of the Galilee, Nahariya, HaZafon
3Faculty of Medicine, Bar-Ilan University, Safed, HaZafon

Background: The long-term prognostic significance of ventricular late potentials (VLP) in patients post ST-elevation myocardial infarction (STEMI) is unclear.  

Methods: This is an observational retrospective study. We conducted serial signal-averaged electrocardiography (SAECG) measurements on the 1st, 2nd and 3rd day post STEMI, pre-discharge and 30 days post admission in patients with STEMI. We followed the patients for 10 years, and correlated VLP with all-cause and cardiovascular mortality.

Results: We studied 63 consecutive patients. The mean age was 59.9±12.3 years and 54 were males (86%). Thrombolytic therapy was administered to 41 patients (65%). Percutaneous coronary intervention (PCI) was performed pre-discharge in 40 patients (63%) and coronary artery bypass grafting (CABG) in 7 patients (11%). During the following decade 14 patients died (22%), 10 (70%) from cardiovascular complications. We found the highest prevalence of VLPs on the 3rd day post STEMI and in males compared with females (QRS- segment> 114 msec: 51% vs. 12%, p=0.02, high frequency low amplitude (HFLA) signal> 38 msec: 47% vs. 25%, p=0.05). There was a higher prevalence of VLPs in patients with RCA as the culprit vessel (QRS- segment>114msec: 62% vs. 34%, p=0.07, HFLA signal>38msec: 52% vs. 37%, p=0.07). However, over 10 years of follow up, there was a trend for higher mortality in patients with VLPs (p=0.125). We could not find a correlation between the presence of VLPs and reduced LV function, age or any of the traditional risk factors.

Conclusions: VLPs do not provide any very long-term prognostic value in patients post STEMI undergoing primary reperfusion. Larger prospective studies are warranted in order to determine whether VLPs may still be used as a marker of higher long-term mortality risk.

 









Powered by Eventact EMS